Ambuja Cements Limited (AMBUJACEM)
Press Release
Press Release - Q2FY27
- Cement sales volume 16.5 MnT; trade volumes +8.6% y-y; trade share 74%, premium products 37% of trade sales
- Revenue from operations Rs 9,197 Cr; Operating EBITDA Rs 1,271 Cr; EBITDA margin 13.8%; EBITDA per tonne Rs 770
- Commissioned 4.6 MTPA capacity in Q2; 3.2 MTPA ramping up in H2 FY27
- One Cement Platform merger of ACC and Orient with Ambuja approved by shareholders; completion expected FY27
- Cost target Rs 4,250 per tonne by FY27; volumes expected to grow ahead of industry in H2 FY27
- Industry outlook cautious due to geopolitical and energy cost pressures; structural demand supported by infrastructure and housing
- Debt-free balance sheet; net worth Rs 72,238 Cr; cash Rs 1,070 Cr; highest AAA/A1+ credit ratings
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 AMBUJACEM — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add AMBUJACEM to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Ambuja Cements Limited
Important.
The summary above is generated automatically from Ambuja Cements Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.